170 related articles for article (PubMed ID: 15853162)
1. Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.
Wampler MA; Hamolsky D; Hamel K; Melisko M; Topp KS
Clin J Oncol Nurs; 2005 Apr; 9(2):189-93. PubMed ID: 15853162
[TBL] [Abstract][Full Text] [Related]
2. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
Maxwell C
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
Wickham R
Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
[TBL] [Abstract][Full Text] [Related]
5. The reliability and validity of a modified total neuropathy score-reduced and neuropathic pain severity items when used to measure chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums.
Smith EM; Cohen JA; Pett MA; Beck SL
Cancer Nurs; 2010; 33(3):173-83. PubMed ID: 20357656
[TBL] [Abstract][Full Text] [Related]
6. Current methods for the assessment and management of taxane-related neuropathy.
Smith EM
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700
[TBL] [Abstract][Full Text] [Related]
7. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
Eckhoff L; Knoop A; Jensen MB; Ewertz M
Eur J Cancer; 2015 Feb; 51(3):292-300. PubMed ID: 25541155
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced pain and neuropathy: a prospective study in patients treated with adjuvant oxaliplatin or docetaxel.
Ventzel L; Jensen AB; Jensen AR; Jensen TS; Finnerup NB
Pain; 2016 Mar; 157(3):560-568. PubMed ID: 26529271
[TBL] [Abstract][Full Text] [Related]
9. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
Taxane-related Peripheral Neuropathy Standardized Management Group
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
[TBL] [Abstract][Full Text] [Related]
10. Clinical challenges: chemotherapy-induced peripheral neuropathy.
Paice JA
Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S8-19. PubMed ID: 19447319
[TBL] [Abstract][Full Text] [Related]
11. A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Kuroi K; Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Watanabe T; Bain S; Hausheer FH
Jpn J Clin Oncol; 2008 Nov; 38(11):748-54. PubMed ID: 18845520
[TBL] [Abstract][Full Text] [Related]
12. Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments.
Kiser DW; Greer TB; Wilmoth MC; Dmochowski J; Naumann RW
Oncol Nurs Forum; 2010 Nov; 37(6):758-64. PubMed ID: 21059587
[TBL] [Abstract][Full Text] [Related]
13. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-related side effects and their management.
Baker J; Ajani J; Scotté F; Winther D; Martin M; Aapro MS; von Minckwitz G
Eur J Oncol Nurs; 2008 Jul; 12(3):253-68. PubMed ID: 18501674
[TBL] [Abstract][Full Text] [Related]
15. Techniques for the neurological examination of taxane-induced neuropathy.
Ohsumi S; Sunada Y
Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799
[TBL] [Abstract][Full Text] [Related]
16. Unilateral taxane-induced onychopathy in a patient with a brain metastasis.
Truchuelo M; Vano-Galvan S; Pérez B; Muñoz-Zato E; Jaén P
Dermatol Online J; 2009 Mar; 15(3):7. PubMed ID: 19379651
[TBL] [Abstract][Full Text] [Related]
17. Long-term peripheral neuropathy symptoms in breast cancer survivors.
Mustafa Ali M; Moeller M; Rybicki L; Moore HCF
Breast Cancer Res Treat; 2017 Nov; 166(2):519-526. PubMed ID: 28791499
[TBL] [Abstract][Full Text] [Related]
18. Difficult cases in pain management: use of methadone in a multifactorial approach.
Griffie J; Coyne P; Coyle N
Clin J Oncol Nurs; 2006 Feb; 10(1):45-9. PubMed ID: 16482727
[TBL] [Abstract][Full Text] [Related]
19. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of spinal cord stimulators in treating peripheral neuropathy: a case series.
Abd-Elsayed A; Schiavoni N; Sachdeva H
J Clin Anesth; 2016 Feb; 28():74-7. PubMed ID: 26395919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
